Fred R. Hirsch, MD, PhD, investigator at the University of Colorado Cancer Center, professor of Medicine and Pathology at the University of Colorado Cancer Center and School of Medicine, and CEO of the International Association for the Study of Lung Cancer (IASLC), helped initiate the beginning of Lung Cancer Awareness Month (LCAM) at the beginning of November with a press conference at the National Press Club in Washington D.C. Dr. Hirsch’s briefing focused on the latest scientific advances in the field of lung cancer treatment and care and IASLC’s efforts to create a harmonized public awareness campaign with a consortium of patient advocate organizations and individuals.
“It is important to spread the message that lung cancer affects everyone: young and old, rich and poor, smoker and non-smoker. The stigma that exists and suggests otherwise is factually and fundamentally untrue. It was important that this November’s Lung Cancer Awareness Month reflect this. The IASLC, being the only global organization dedicated solely to fighting lung cancer, is the organization best equipped to bring people together to dispel stigma through an organized campaign focused on survivors and the advances currently being made in the field,” Dr. Hirsch said of the campaign and IASLC’s organizational role. That was the reason for Dr. Hirsch and the IASLC to take the initiative in bringing various advocate groups together around a common campaign.